胃轻瘫

Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592-1622.

• 全文
• 摘要

1.  Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592-1622.

• 全文
• 摘要

2.  Dong K, Yu XJ, Li B, et al. Advances in mechanisms of postsurgical gastroparesis syndrome and its diagnosis and treatment. Chin J Dig Dis. 2006;7:76-82.

• 摘要

3.  Balaji NS, Crookes PF, Banki F, et al. A safe and noninvasive test for vagal integrity revisited. Arch Surg. 2002;137:954-958.

• 摘要

4.  Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989-1996.

• 摘要

5.  Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808-2816.

• 摘要

6.  Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001;24:1264-1269.

• 摘要

7.  Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med. 1987;28:1204-1207.

• 摘要

8.  Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut. 1996;39:299-305.

• 摘要

9.  Jacob A, Pittock SJ. Gastroparesis in multiple sclerosis. Mult Scler. 2007;13:686.

• 摘要

10.  Raghav S, Kipp D, Watson J, et al. Gastroparesis with multiple sclerosis. Mult Scler. 2006;12:243-244.

• 摘要

11.  Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology. 1985;88:1223-1231.

• 摘要

12.  Balaban DH, Chen J, Lin Z, et al. Median arcuate ligament syndrome: a possible cause of idiopathic gastroparesis. Am J Gastroenterol. 1997;92:519-523.

• 摘要

13.  Patrick A, Epstein O. Review article: gastroparesis. Aliment Pharmacol Ther. 2008;27:724-740.

• 全文
• 摘要

14.  Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999;44:1061-1075.

• 摘要

15.  Hinder RA, Kelly KA. Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg. 1977;133:29-33.

• 摘要

16.  Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398-2404.

• 摘要

17.  Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986;91:94-99.

• 摘要

18.  Houghton LA, Read NW, Heddle R, et al. Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology. 1988;94:1285-1291.

• 摘要

19.  Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986;90:1919-1925.

• 摘要

20.  Forster J, Damjanov I, Lin Z, et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg. 2005;9:102-108.

• 摘要

21.  Zarate N, Mearin F, Wang XY, et al. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut. 2003;52:966-970.

• 摘要

22.  Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology. 1995;108:727-736.

• 摘要

23.  Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:675-680.

• 摘要

24.  Hunter RJ, Metz DC, Morris JB, et al. Gastroparesis: a potential pitfall of laparoscopic Nissen fundoplication. Am J Gastroenterol. 1996;91:2617-2618.

• 摘要

25.  Reddymasu SC, Bonino J, McCallum RW. Gastroparesis secondary to a demyelinating disease: a case series. BMC Gastroenterol. 2007;7:3.

• 摘要

26.  Cetin K, Gungor B, Isik A, et al. The effect of pneumatic balloon dilatation on gastric emptying in patients with achalasia. Hepatogastroenterology. 2003;50(suppl 2):ccci-cccii.

• 摘要

27.  Benini L, Sembenini C, Salandini L, et al. Gastric emptying of realistic meals with and without gluten in patients with coeliac disease. Effect of jejunal mucosal recovery. Scand J Gastroenterol. 2001;36:1044-1048.

• 摘要

28.  Perri F, Pastore M, Zicolella A, et al. Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal. Acta Paediatr. 2000;89:921-925.

• 摘要

29.  Zipfel S, Sammet I, Rapps N, et al. Gastrointestinal disturbances in eating disorders: clinical and neurobiological aspects. Auton Neurosci. 2006;129:99-106.

• 摘要

30.  Goetze O, Wieczorek J, Mueller T, et al. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci Lett. 2005;375:170-173.

• 摘要

31.  Goetze O, Nikodem AB, Wiezcorek J, et al. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil. 2006;18:369-375.

• 摘要

32.  Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol. 1996;8:569-575.

• 摘要

33.  Sridhar KR, Lange RC, Magyar L, et al. Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications. J Lab Clin Med. 1998;132:541-546.

• 摘要

34.  Marie I, Levesque H, Ducrotte P, et al. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol. 2001;96:77-83.

• 摘要

35.  Shih WJ, DeLand FH, Domstad PA, et al. Scintigraphic findings in primary amyloidosis of the heart and stomach. Clin Nucl Med. 1985;10:466-467.

• 摘要

36.  Jonderko G, Jonderko K, Marcisz C, et al. Evaluation of gastric emptying in patients with hypothyroidism [in Polish]. Pol Arch Med Wewn. 1996;96:117-123.

• 摘要

37.  Kahraman H, Kaya N, Demircali A, et al. Gastric emptying time in patients with primary hypothyroidism. Eur J Gastroenterol Hepatol. 1997;9:901-904.

• 摘要

38.  Van Vlem B, Schoonjans R, Vanholder R, et al. Dyspepsia and gastric emptying in chronic renal failure patients. Clin Nephrol. 2001;56:302-307.

• 摘要

39.  Van Vlem B, Schoonjans R, Vanholder R, et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis. 2000;36:962-968.

• 摘要

40.  Naftali T, Yishai R, Zangen T, et al. Post-infectious gastroparesis: clinical and electrogastrographic aspects. J Gastroenterol Hepatol. 2007;22:1423-1428.

• 摘要

41.  Eisenberg D. Gastroparesis and herpes. Dig Dis Sci. 1988;33:1050.

• 摘要

42.  Caras S, Laurie S, Cronk W, et al. Case report: pancreatic cancer presenting with paraneoplastic gastroparesis. Am J Med Sci. 1996;312:34-36.

• 摘要

43.  Berghmans T, Musch W, Brenez D, et al. Paraneoplastic gastroparesis. Rev Med Brux. 1993;14:275-278.

• 摘要

44.  Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil. 2004;16(suppl 2):17-28.

• 摘要

45.  Parkman HP, Trate DM, Knight LC, et al. Cholinergic effects on human gastric motility. Gut. 1999;45:346-354.

• 摘要

46.  Foxx-Orenstein A, Camilleri M, Stephens D, et al. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut. 2003;52:1555-1561.

• 摘要

47.  Tougas G, Earnest DL, Chen Y, et al. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod. Aliment Pharmacol Ther. 2005;22:59-65.

• 摘要

48.  Nishiguchi S, Shiomi S, Kurooka H, et al. Randomized trial assessing gastric emptying in patients with chronic hepatitis C during interferon-alpha or -beta therapy and effect of cisapride. Dig Dis Sci. 2002;47:73-78.

• 摘要

49.  Hardoff R, Sula M, Tamir A, et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord. 2001;16:1041-1047.

• 摘要

50.  Young A. Inhibition of gastric emptying. Adv Pharmacol. 2005;52:99-121.

• 摘要

51.  Jonderko K, Jonderko G, Golab T. Effect of calcitonin on gastric emptying and on serum insulin and gastrin concentrations after ingestion of a mixed solid-liquid meal in humans. J Clin Gastroenterol. 1990;12:22-28.

• 摘要

52.  Franke A, Nakchbandi IA, Schneider A, et al. The effect of ethanol and alcoholic beverages on gastric emptying of solid meals in humans. Alcohol. 2005;40:187-193.

• 摘要

53.  Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician. 2005;71:2123-2128.

• 摘要

54.  Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006;101:1129-1139.

• 摘要

55.  Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456-1462.

• 摘要

56.  Lin HC, Prather C, Fisher RS, et al. Measurement of gastrointestinal transit. Dig Dis Sci. 2005;50:989-1004.

• 摘要

57.  Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103:753-763.

• 全文
• 摘要

58.  Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008;27:186-196.

• 全文
• 摘要

59.  Mark DH. Wireless motility capsule in the diagnosis and evaluation of gastroparesis or slow-transit constipation (Provisional abstract). Database of Abstracts of Reviews of Effects. 2012;1.

60.  Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004;13:833-844.

• 摘要

61.  Namin F, Patel J, Lin Z, et al. Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. Neurogastroenterol Motil. 2007;19:196-202.

• 摘要

62.  Fleisher DR, Gornowicz B, Adams K, et al. Cyclic vomiting syndrome in 41 adults: the illness, the patients, and problems of management. BMC Med. 2005;3:20.

• 全文
• 摘要

63.  Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390.

• 摘要

64.  Koskenpato J, Kairemo K, Korppi-Tommola T, et al. Role of gastric emptying in functional dyspepsia: a scintigraphic study of 94 subjects. Dig Dis Sci. 1998;43:1154-1158.

• 摘要

65.  Soykan I, Chen J, Kendall BJ, et al. The rumination syndrome: clinical and manometric profile, therapy, and long-term outcome. Dig Dis Sci. 1997;42:1866-1872.

• 摘要

66.  O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology. 1995;108:1024-1029.

• 摘要

67.  European Medicines Agency. CMDh confirms recommendations on restricting use of domperidone-containing medicines. April 2014. http://www.ema.europa.eu/ (last accessed 20 June 2016).

• 全文

68.  McCallum RW, Ricci DA, Rakatansky H, et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care. 1983;6:463-467.

• 摘要

69.  Ricci DA, Saltzman MB, Meyer C, et al. Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol. 1985;7:25-32.

• 摘要

70.  European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013. http://www.ema.europa.eu/ (last accessed 20 June 2016).

• 全文

71.  Ganzini L, Casey DE, Hoffman WF, et al. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993;153:1469-1475.

• 摘要

72.  Shaffer D, Butterfield M, Pamer C, et al. Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. J Am Pharm Assoc (2003). 2004;44:661-665.

• 摘要

73.  Cavero-Redondo I, Álvarez-Bueno C, Pozuelo-Carrascosa DP, et al. Risk of extrapyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration: a systematic review and meta-analysis of randomised controlled trials. J Clin Nurs. 2015;24:3638-3646.

• 摘要

74.  Stewart JJ, Wood MJ, Wood CD, et al. Effects of motion sickness and antimotion sickness drugs on gastric function. J Clin Pharmacol. 1994;34:635-643.

• 摘要

75.  Sawhney MS, Prakash C, Lustman PJ, et al. Tricyclic antidepressants for chronic vomiting in diabetic patients. Dig Dis Sci. 2007;52:418-424.

• 摘要

76.  Parkman HP, Van Natta ML, Abell TL, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. JAMA. 2013;310:2640-2649.

• 全文
• 摘要

77.  Maurer AH, Krevsky B, Knight LC, et al. Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy. J Nucl Med. 1996;37:818-822.

• 摘要

78.  Mercadante S, Casuccio A, Fulfaro F, et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol. 2001;19:2898-2904.

• 摘要

79.  Tawfik MO, Bryuzgin V, Kourteva G; FEN-INT-20 Study Group. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain. Curr Med Res Opin. 2004;20:259-267.

• 摘要

80.  Olausson EA, Störsrud S, Grundin H, et al. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014;109:375-385.

• 摘要

81.  Abell TL, Bernstein RK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil. 2006;18:263-283.

• 摘要

82.  Bromer MQ, Friedenberg F, Miller LS, et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc. 2005;61:833-839.

• 摘要

83.  Arts J, van Gool S, Caenepeel P, et al. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther. 2006;24:661-667.

• 摘要

84.  Bai Y, Xu MJ, Yang X, et al. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion. 2010;81:27-34.

• 摘要

85.  Soffer E, Abell T, Lin Z, et al. Review article: gastric electrical stimulation for gastroparesis - physiological foundations, technical aspects and clinical implications. Aliment Pharmacol Ther. 2009;30:681-694.

• 摘要

86.  Chu H, Lin Z, Zhong L, et al. Treatment of high-frequency gastric electrical stimulation for gastroparesis. J Gastroenterol Hepatol. 2012;27:1017-1026.

• 全文
• 摘要

87.  Yin J, Abell TD, McCallum RW, et al. Gastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesis. Neuromodulation. 2012;15:224-231.

• 摘要

88.  McCallum RW, Sarosiek I, Parkman HP, et al. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil. 2013;25:815-e636.

• 全文
• 摘要

89.  Lin Z, McElhinney C, Sarosiek I, et al. Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations. Dig Dis Sci. 2005;50:1328-1334.

• 摘要

90.  Cutts TF, Luo J, Starkebaum W, et al. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil. 2005;17:35-43.

• 摘要

91.  O'Grady G, Egbuji JU, Du P, et al. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg. 2009;33:1693-1701.

• 摘要

92.  National Institute for Health and Care Excellence. Gastroelectrical stimulation for gastroparesis. May 2014. https://www.nice.org.uk (last accessed 20 June 2016).

• 全文

93.  Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol. 2003;98:2122-2129.

• 摘要

94.  McCallum RW, Cynshi O; US Investigative Team. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther. 2007;26:107-116.

• 摘要

95.  Mackie AD, Ferrington C, Cowan S, et al. The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis. Aliment Pharmacol Ther. 1991;5:135-142.

• 摘要

96.  Asakawa H, Hayashi I, Fukui T, et al. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. Diabetes Res Clin Pract. 2003;61:175-182.

• 摘要

97.  He J, Wang Y, Ouyang X. Mosapride in treatment of diabetic gastroparesis: a meta-analysis. Chin J Gastroenterol. 2011;16:94-98.

98.  Seto K, Sasaki T, Katsunuma K, et al. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil. 2008;20:1051-1059.

• 摘要

99.  Dornonville de la Cour C, Lindström E, Norlén P, et al. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept. 2004;120:23-32.

• 摘要

100.  Sallam HS, Chen JD. The prokinetic face of ghrelin. Int J Pept. 2010;493614:1-11.

• 全文
• 摘要

101.  Tack J. Gastric motor disorders. Best Pract Res Clin Gastroenterol. 2007;21:633-644.

• 摘要

102.  Lacy BE, Weiser K. Gastrointestinal motility disorders: an update. Dig Dis. 2006;24:228-242.

• 摘要

103.  Thorn AR. Not just another case of nausea and vomiting: a review of postinfectious gastroparesis. J Am Acad Nurse Pract. 2010;22:125-133.

• 摘要

104.  Jung HK, Choung RS, Locke GR 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225-1233.

• 全文
• 摘要